Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 5
Submit an article Journal homepage
473
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Non-relapse mortality in pediatric acute lymphoblastic leukemia: a systematic review and meta-analysis

Esther BlancoDivision of Haematology/Oncology, Department of Paediatrics;Department of Paediatrics
,
Joseph BeyeneProgram in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada;Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada;Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada
,
Anne Marie MaloneyDivision of Haematology/Oncology, Department of Paediatrics
,
Rowena AlmeidaProgram in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada
,
Marie-Chantal EthierProgram in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada
,
Naomi WinickDepartment of Pediatric Hematology/Oncology, UT Southwestern Medical Center, Dallas, TX, USA
,
Sarah AlexanderDivision of Haematology/Oncology, Department of Paediatrics;Department of Paediatrics
&
Lillian SungDivision of Haematology/Oncology, Department of Paediatrics;Department of Paediatrics;Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, CanadaCorrespondence[email protected]
 show all
Pages 878-885 | Received 11 Aug 2011, Accepted 05 Nov 2011, Published online: 03 Jan 2012

References

  • Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer 2008;112:416–432.
  • Baade PD, Youlden DR, Valery PC, . Trends in incidence of childhood cancer in Australia, 1983-2006. Br J Cancer 2010; 102:620–626.
  • Pui CH. Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc 2010;109:777–787.
  • Lund B, Asberg A, Heyman M, . Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer 2011;56:551–559.
  • Moricke A, Reiter A, Zimmermann M, . Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008;111:4477–4489.
  • Hargrave DR, Hann II, Richards SM, . Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol 2001;112:293–299.
  • Vilmer E, Suciu S, Ferster A, . Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Leukemia 2000;14: 2257–2266.
  • Conter V, Arico M, Valsecchi MG, . Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982–1995. Leukemia 2000;14:2196–2204.
  • Rubnitz JE, Lensing S, Zhou Y, . Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer 2004;101:1677–1684.
  • Slats AM, Egeler RM, van der Does-van den Berg A, . Causes of death—other than progressive leukemia—in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia 2005;19:537–544.
  • Prucker C, Attarbaschi A, Peters C, . Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster study group. Leukemia 2009; 23:1264–1269.
  • Moghrabi A, Levy DE, Asselin B, . Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 2007;109:896–904.
  • Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144: 427–437.
  • Bieler GS, Williams RL. Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity. Biometrics 1993;49:793–801.
  • Smith M, Arthur D, Camitta B, . Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:18–24.
  • Lange BJ, Smith FO, Feusner J, . Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group. Blood 2008;111:1044–1053.
  • Moher D, Pham B, Klassen TP, . What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol 2000;53:964–972.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.